Basics Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health. IPO Date: April 1, 1993 Sector: Healthcare Industry: Biotech Market Cap: $215.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 3.52% Avg Daily Range (30 D): $0.28 | 3.46% Avg Daily Range (90 D): $0.12 | 3.45% Institutional Daily Volume Avg Daily Volume: 2.79M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .96M Trade Size Avg Trade Size (Sh.): 306 Avg Trade Size (Sh.) (30 D): 287 Avg Trade Size (Sh.) (90 D): 529 Institutional Trades Total Inst.Trades: 4,766 Avg Inst. Trade: $1.27M Avg Inst. Trade (30 D): $1.38M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $.8M Avg Closing Volume: 6.65K         News Mar 12, 2025 @ 11:01 AM Amarin Announces Plan to Initiate a Ratio Change U... Source: Amarin Corporation Plc Dec 13, 2024 @ 2:00 PM Amarin Appoints Peter Fishman Chief Financial Offi... Source: N/A Jun 4, 2024 @ 11:30 AM Amarin Board of Directors Announces CEO Transition... Source: Amarin Corporation plc May 28, 2024 @ 12:15 PM  Amarin Receives National Reimbursement for VAZ... Source: Amarin Corporation plc May 6, 2024 @ 12:00 PM Amarin to Present at H.C. Wainwright 2nd Annual Bi... Source: Amarin Corporation plc Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.22 $-.04 $-.12 Diluted EPS $-.22 $-.04 $-.12 Revenue $ 214.11M $ 42.02M $ 62.31M Gross Profit $ 74.61M $ 25.13M $ -9.57M Net Income / Loss $ -87.93M $ -15.7M $ -48.62M Operating Income / Loss $ -94.97M $ -16.76M $ -52.52M Cost of Revenue $ 139.5M $ 16.89M $ 71.87M Net Cash Flow $ -94.65M $ -1.51M $ -36.13M PE Ratio     Splits Apr 11, 2025:   20:1 Jan 18, 2008:   10:1